{"id":209789,"date":"2024-11-27T09:37:00","date_gmt":"2024-11-27T13:37:00","guid":{"rendered":"https:\/\/inspenet.com\/?p=209789"},"modified":"2024-11-27T09:06:19","modified_gmt":"2024-11-27T13:06:19","slug":"neuralink-advances-brain-implant-research-with-assistive-robotic-arm","status":"publish","type":"noticias","link":"https:\/\/inspenet.com\/en\/news\/neuralink-advances-brain-implant-research-with-assistive-robotic-arm\/","title":{"rendered":"Neuralink advances brain implant research with assistive robotic arm"},"content":{"rendered":"\n

Neuralink<\/strong> , the neurotechnology company founded by Elon Musk<\/a><\/strong> , has received approval to launch a new feasibility study that expands its brain-computer interface (BCI)<\/strong> technology<\/strong> . This innovative trial seeks to evaluate the ability of the N1 brain implant<\/a><\/strong> to control an assistive robotic arm<\/a><\/strong> in patients with limited mobility due to spinal cord injuries or neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). <\/p>\n\n

CONVOY: The Neuralink feasibility study<\/h2>\n\n

The study, called CONVOY<\/strong> , is a crucial step in the development of neurotechnology that could transform the lives of people with severe paralysis. Through this trial, Neuralink plans to evaluate the effectiveness of the brain implant in restoring motor control<\/strong> and the ability to interact with external devices solely through thought, without the need for physical movements. <\/p>\n\n

The N1 brain implant<\/strong> is designed to be fully implantable and wireless, making it an attractive option for patients with limited physical capabilities. Through this device, Neuralink hopes to enhance neural functionality and allow people to control an assistive robot with remarkable precision<\/strong> , opening up new possibilities in technological rehabilitation. <\/p>\n\n

The trial will also allow cross-enrollment of participants from the ongoing PRIME study<\/a><\/strong> in the United States. This multidimensional approach will provide valuable data on the safety and feasibility of the BCI technology, propelling Neuralink toward the goal of transforming robotic medicine and surgery. <\/p>\n\n

Neuralink expands its horizons internationally<\/h2>\n\n

With the recent approval from Health Canada<\/strong> , Neuralink<\/strong> is also initiating its first international clinical trial, the CAN-PRIME study<\/a><\/strong> , which will be conducted in Canada. This study, which follows on the heels of the PRIME trial in the U.S., represents a significant step toward globally expanding the capabilities of neurotechnology in the care of patients with paralysis. <\/p>\n\n

While this is just the beginning, the advances made so far in the field of neurotechnology and robotic surgery could have momentous implications for modern medicine. Neuralink, with the support of its innovations, is leading the way to a new era of medical solutions that could restore mobility and improve the quality of life for millions of people around the world. <\/p>\n\n

Follow us on social networks and don’t miss any of our publications!<\/strong><\/p>\n\n

YouTube<\/a> LinkedIn<\/a> Facebook<\/a> Instagram<\/a> X<\/a><\/p>\n\n

Source<\/strong> : Neuralink via X<\/a><\/strong><\/p>\n\n

Photo: shutterstock<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

The N1 brain implant would allow severely paralyzed people to control an assistive robotic arm using only their thoughts.<\/p>\n","protected":false},"author":8403,"featured_media":209676,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categoria_noticias":[13030,13058],"etiqueta_noticias":[],"class_list":["post-209789","noticias","type-noticias","status-publish","has-post-thumbnail","hentry","categoria_noticias-industry","categoria_noticias-robotics"],"acf":[],"_links":{"self":[{"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/noticias\/209789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/users\/8403"}],"replies":[{"embeddable":true,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/comments?post=209789"}],"version-history":[{"count":0,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/noticias\/209789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/media\/209676"}],"wp:attachment":[{"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/media?parent=209789"}],"wp:term":[{"taxonomy":"categoria_noticias","embeddable":true,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/categoria_noticias?post=209789"},{"taxonomy":"etiqueta_noticias","embeddable":true,"href":"https:\/\/inspenet.com\/en\/wp-json\/wp\/v2\/etiqueta_noticias?post=209789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}